Uses of 2-bromopalmitate in the treatment of autoimmune disease
US6890954B1 · kind B1 · utility
1Cited by
1References
9Claims
0Family size
Inventors
Key dates
| Filing date | Sep 22, 2000 |
| Grant date | May 10, 2005 |
| Priority date | — |
| Expiry date | May 29, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method of inhibiting Fyn/Lck fatty acylation and protein palmitoylation in a cell in an individual in need of such treatment comprising the step of administering to said individual a pharmacologically effective dose of 2-bromopalmitate. Also provided is a method of treating an individual having an autoimmune disease comprising the step of administering to said individual a pharmacologically effective dose of 2-bromopalmitate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.